The standard of the Dutch College of General Practitioners on atopic dermatitis: First revision;NHG-Standaard Constitutioneel eczeem: Eerste herziening

Huisarts en Wetenschap

Volumn 49, Issue 9, 2006, Pages 458-465

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ATOPIC DERMATITIS; GENERAL PRACTITIONER; MEDICAL SCHOOL; SHORT SURVEY;

EID: 33750372731     PISSN: 00187070     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (56)

1. Anonymus. Richtlijn Dermatocorticosteroïden. Utrecht: Nederlandse Vereniging van Dermatologie en Venerologie, 2000.
2. Ashcroft DM, Dimmock P, Garside R, Stein K, Williams HC. Efficacy and tolerability of topical pimecrolimus and tacrolimus in the treatment of atopic dermatitis: meta-analysis of randomised controlled trials. BMJ 2005;330:516-22.
3. Ben-Gashir MA, Hay RJ. Reliance on erythema scores may mask severe atopic dermatitis in black children compared with their white counterparts. Br J Dermatol 2002;147:920-5.
4. Bendsöe N, Bjornberg A, Asnes H. Itching from wool fibres in atopic dermatitis. Contact Dermatitis 1987;17:21-2.
5. Benn CS, Wohlfahrt J, Aaby P, Westergaard T, Benfeldt E, Michaelsen KF, et al. Breastfeeding and risk of atopic dermatitis, by parental history of allergy, during the first 18 months of life. Am J Epidemiol 2004;160:217-23.
6. Berth-Jones J, Damstra RJ, Golsch S, Livden JK, Van Hooteghem O, Allegra F, et al. Twice weekly fluticasone propionate added to emollient maintenance treatment to reduce risk of relapse in atopic dermatitis: randomised, double blind, parallel group study. BMJ 2003;326:1367-70.
7. Charman CR, Venn AJ, Williams H, Bigby M. Measuring atopic eczema severity visually: which variables are most important to patients? Arch Dermatol 2005;141:1146-51.
8. Commissie Farmaceutische Hulp van het College voor zorgverzekeringen. Farmacotherapeutisch Kompas: medisch farmaceutische voorlichting. Amstelveen: CVZ, 2006.
9. Cookson WO, Moffatt MF. The genetics of atopic dermatitis. Curr Opin Allergy Clin Immunol 2002;2:383-7.
10. De Bruin-Weller MS, Bruijnzeel-Koomen CAFM. Topicale immunosuppressiva zoals tacrolimus en pimecrolimus bij de behandeling van constitutioneel eczeem. Ned Tijdschr Geneeskd 2005;149:1096-100.
11. De Gier JJ. Commentaren medicatiebewaking 2005/2006. Houten: Stichting Health Base, 2005.
12. Diepgen TL, Stabler A, Hornstein OP. Textil-unverträglichkeit beim atopischen Ekzem - Eine kontrollierte klinische Studie. Z Hautkr 1990;65:907-10.
13. EMEA. European medicines agency recommends cautious use of Protopic/Protopy and Elidel. http://www.emea.eu.int/pdfs/general/direct/pr/ 9888206en.pdf; geraadpleegd op 27 april 2006.
14. Flohr C, Johansson SG, Wahlgren CF, Williams H. How atopic is atopic dermatitis? J Allergy Clin Immunol 2004;114:150-8.
15. Friedmann PS, Holden CA. Atopic dermatitis. In: Burns T, Breathnach S, Cox N, Griffiths C, editors. Rook's textbook of dermatology. Oxford: Blackwell, 2004: 18.1-18.31.
16. Furue M, Terao H, Rikihisa W, Urabe K, Kinukawa N, Nose Y, et al. Clinical dose and adverse effects of topical steroids in daily management of atopic dermatitis. Br J Dermatol 2003;148:128-33.
17. Gdalevich M, Mimouni D, David M, Mimouni M. Breast-feeding and the onset of atopic dermatitis in childhood: a systematic review and meta-analysis of prospective studies. J Am Acad Dermatol 2001;45:520-7.
18. Gerth van Wijk R, Van Cauwenberge PB, Johansson SG. Herziene terminologie voor allergie en verwante aandoeningen. Ned Tijdschr Geneeskd 2002;146:2289-93.
19. Green C, Colquitt JL, Kirby J, Davidson P. Topical corticosteroids for atopic eczema: clinical and cost effectiveness of once-daily vs. more frequent use. Br J Dermatol 2005;152:130-41.
20. Gu H, Chen XS, Chen K, Yan Y, Jing H, Chen XQ, et al. Evaluation of diagnostic criteria for atopic dermatitis: validity of the criteria of Williams et al. in a hospital-based setting. Br J Dermatol 2001;145:428-33.
21. Gustafsson D, Sjoberg O, Foucard T. Development of allergies and asthma in infants and young children with atopic dermatitis - a prospective follow-up to 7 years of age. Allergy 2000;55:240-5.
22. Gutgesell C, Heise S, Seubert S, Seubert A, Domhof S, Brunner E, et al. Double-blind placebo-controlled house dust mite control measures in adult patients with atopic dermatitis. Br J Dermatol 2001;145:70-4.
23. Hanifin JM, Raijka G. Diagnostic features of atopic dermatitis. Acta Dermatovener 1980;92:44-7.
24. Hoare C, Li Wan PA, Williams H. Systematic review of treatments for atopic eczema. Health Technol Assess 2000;4:1-191.
25. Holm L, Bengtsson A, Van Hage-Hamsten M, Ohman S, Scheynius A. Effectiveness of occlusive bedding in the treatment of atopic dermatitis - a placebo-controlled trial of 12 months' duration. Allergy 2001;56:152-8.
26. Illi S, Von Mutius E, Lau S, Nickel R, Gruber C, Niggemann B, et al. The natural course of atopic dermatitis from birth to age 7 years and the association with asthma. J Allergy Clin Immunol 2004;113:925-31.
27. Imai S, Takeuchi S, Mashiko T. Jahreszeitliche Änderungen im Verlauf des atopischen Ekzems. Hautarzt 1987;38:599-602.
28. Johansson SG, Bieber T, Dahl R, Friedmann PS, Lanier BQ, Lockey RF, et al. Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003. J Allergy Clin Immunol 2004;113:832-6.
29. Koning S, Suijlekom-Smit LW, Nouwen JL, Verduin CM, Bernsen RM, Oranje AP, et al. Fusidic acid cream in the treatment of impetigo in general practice: double blind randomised placebo controlled trial. BMJ 2002;324:203-6.
30. Koning S, Verhagen AP, Suijlekom-Smit LW, Morris A, Butler CC, Van der Wouden JC. Interventions for impetigo. Cochrane Database Syst Rev 2003;2:CD003261.
31. Kramer MS, Kakuma R. Maternal dietary antigen avoidance during pregnancy and/or lactation for preventing or treating atopic disease in the child. Cochrane Database Syst Rev 2003;4:CD000133.
32. Krämer U, Weidinger S, Darsow U, Mohrenschlager M, Ring J, Behrendt H. Seasonality in symptom severity influenced by temperature or grass pollen: results of a panel study in children with eczema. J Invest Dermatol 2005;124:514-23.
33. Kwaliteitsinstituut voor de gezondheidszorg CBO. Richtlijn Constitutioneel eczeem (in concept). http://www.cbo.nl
34. Linna O, Kokkonen J, Lahtela P, Tammela O. Ten-year prognosis for generalized infantile eczema. Acta Paediatr 1992;81:1013-6.
35. Lucky AW, Leach AD, Laskarzewski P, Wenck H. Use of an emollient as a steroid-sparing agent in the treatment of mild to moderate atopic dermatitis in children. Pediatr Dermatol 1997;14:321-4.
36. Munkvad M. A comparative trial of Clinitar versus hydrocortisone cream in the treatment of atopic eczema. Br J Dermatol 1989;121:763-6.
37. Novak N, Bieber T, Leung DY. Immune mechanisms leading to atopic dermatitis. J Allergy Clin Immunol 2003;112:S128-39.
38. Novak N, Kruse S, Potreck J, Maintz L, Jenneck C, Weidinger S, et al. Single nucleotide polymorphisms of the IL18 gene are associated with atopic eczema. J Allergy Clin Immunol 2005;115:828-33.
39. Okkes IM, Oskam SK, Van Boven K, Lamberts H. Episodes of care in Dutch family practice. Epidemiological data based on the routine use of the International Classification of Primary Care (ICPC) in the Transition Project of the Academic Medical Center/University of Amsterdam (1985-2003). In: Okkes IM, Oskam SK, Lamberts H. ICPC in the Amsterdam Transition Project. (CD-Rom). Amsterdam: Academic Medical Center/University of Amsterdam, Department of Family Medicine, 2005.
40. Costing AJ, De Bruin-Weller MS, Terreehorst I, Tempels-Pavlica Z, Aalberse RC, De Monchy JG, et al. Effect of mattress encasings on atopic dermatitis outcome measures in a double-blind, placebo-controlled study: the Dutch mite avoidance study. J Allergy Clin Immunol 2002;110:500-6.
41. Peeters KABM, Mascini EM, Blok HEM, Sanders CJG. Toename van resistentie tegen fusidinezuur van Staphlococcus aureus-isolaten bij opgenomen patiënten met constitutioneel eczeem. Ned Tijdschr Geneeskd 2002;146:2100-1.
42. Polano MK. Corticosteroïden in de dermatologie. Ned Tijdschr Geneeskd 1977;121:2083-8.
43. Ricci G, Patrizi A, Specchia F, Menna L, Bottau P, D'Angelo V, et al. Effect of house dust mite avoidance measures in children with atopic dermatitis. Br J Dermatol 2000;143:379-84.
44. Tariq SM, Matthews SM, Hakim EA, Stevens M, Arshad SH, Hide DW. The prevalence of and risk factors for atopy in early childhood: a whole population birth cohort study. J Allergy Clin Immunol 1998;101:587-93.
45. Thomas KS, Armstrong S, Avery A, Po AL, O'Neill C, Young S, et al. Randomised controlled trial of short bursts of a potent topical corticosteroid versus prolonged use of a mild preparation for children with mild or moderate atopic eczema. BMJ 2002;324:768.
46. US Food and Drug Administration. Elidel (pimectrolimus). http://www.fda.gov/med-watch/SAFETY/2005/safety05.htm#Elidel; geraadpleegd op 7 april 2005.
47. Van de Kerkhof PC. Teer in de dermatologie. Ned Tijdschr Geneeskd 1989;133:2067-70.
48. Van der Linden MW, Westert GP, De Bakker DH, Schellevis FG. Tweede Nationale Studie naar ziekten en verrichtingen in de huisartspraktijk. Utrecht: NIVEL, 2004.
49. Van der Meer JB1,Glazenburg EJ, Mulder PG, Eggink HF, Coenraads PJ. The management of moderate to severe atopic dermatitis in adults with topical fluticasone propionate. The Netherlands Adult Atopic Dermatitis-Study Group. Br J Dermatol 1999;140:1114-21.
50. Werfel T, Breuer K. Role of food allergy in atopic dermatitis. Curr Opin Allergy Clin Immunol 2004;4:379-85.
51. Williams HC, Burney PG, Hay RJ, Archer CB, Shipley MJ, Hunter JJ, et al. The UK working party's diagnostic criteria for atopic dermatitis. I. Derivation of a minimum set of discriminators for atopic dermatitis. Br J Dermatol 1994a:131:383-96.
52. Williams HC, Burney PG, Pembroke AC, Hay RJ. The UK working party's diagnostic criteria for atopic dermatitis. III. Independent hospital validation. Br J Dermatol 1994b;131:406-16.
53. Williams HC, Burney PG, Pembroke AC, Hay RJ. Validation of the UK diagnostic criteria for atopic dermatitis in a population setting. UK Diagnostic Criteria for Atopic Dermatitis Working Party. Br J Dermatol 1996;135:12-7.
54. Williams HC. Clinical practice. Atopic dermatitis. N Engl J Med 2005;352:2314-24.
55. Williams JR, Burr ML, Williams HC. Factors influencing atopic dermatitis - a questionnaire survey of schoolchildren's perceptions. Br J Dermatol 2004;150:1154-61.
56. Wolkerstorfer A, De Waard van der Spek FB, Glazenburg EJ, Mulder PG, Oranje AP. Scoring the severity of atopic dermatitis: three item severity score as a rough system for daily practice and as a pre-screening tool for studies. Acta Derm Venereol 1999;79:356-9.